Amy Cipau

Amy is a member of Improvita’s Board of Directors. She has held roles driving the commercial and product strategy for pharmaceutical companies including: Catalytica Pharmaceuticals, Medco Research, and Burroughs Wellcome Company. Amy was the President of the North Carolina Lung Cancer Partnership, and 6 years ago she founded, and is now President of, the Lung Cancer Initiative of North Carolina, a non-profit organization supporting lung cancer research and education. Amy  obtained her BA in Psychology from East Carolina University, and her MBA from the University of North Carolina-Chapel Hill.